Assignment of Assignor's Interest

Recorded: 2012-08-30 Pages: 6

Assignor

KERYX BIOPHARMACEUTICALS, INC.

Executed: 2012-08-06

Assignee

AETERNA ZENTARIS GMBH

WEISMUELLERSTRASSE 50, FRANKFURT AM MAIN, D-60314, GERMANY

Covered Property (1)

Perifosine and Capecitabine as a Combined Treatment for Cancer

Patent: 8,383,607 →

Application: 13/077,766 →

Publication: US 2011/0243933

Related Assignments (1)

Other recorded transfers of the patent in this record — the chain of ownership.